{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:44:49Z","timestamp":1780569889248,"version":"3.54.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CHDDT"],"published-print":{"date-parts":[[2008,6,1]]},"DOI":"10.2174\/187152908784533748","type":"journal-article","created":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T06:41:36Z","timestamp":1212475296000},"page":"138-146","source":"Crossref","is-referenced-by-count":9,"title":["The Role of Tirofiban in the Management of Coronary Artery Disease"],"prefix":"10.2174","volume":"8","author":[{"given":"Julian","family":"Winter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Juergens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Cardiovascular & Hematological Disorders-Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/67033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T09:54:28Z","timestamp":1448272468000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1871-529X&volume=8&issue=2&spage=138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,1]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/187152908784533748","relation":{},"ISSN":["1871-529X"],"issn-type":[{"value":"1871-529X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6,1]]}}}